News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,037 Results
Type
Article (6907)
Company Profile (111)
Press Release (164019)
Multimedia
Podcasts (47)
Webinars (7)
Section
Business (54127)
Career Advice (359)
Deals (9833)
Drug Delivery (30)
Drug Development (32079)
Employer Resources (69)
FDA (2748)
Job Trends (4184)
News (97021)
Policy (6811)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (1)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (265)
Accelerated approval (1)
Adcomms (2)
Allergies (28)
Alliances (12371)
ALS (34)
Alzheimer's disease (391)
Antibody-drug conjugate (ADC) (56)
Approvals (2774)
Artificial intelligence (73)
Autoimmune disease (8)
Automation (1)
Bankruptcy (65)
Best Places to Work (3251)
BIOSECURE Act (14)
Biosimilars (42)
Biotechnology (73)
Bladder cancer (18)
Brain cancer (13)
Breast cancer (59)
Cancer (651)
Cardiovascular disease (42)
Career advice (311)
Career pathing (21)
CAR-T (55)
Cell therapy (136)
Cervical cancer (4)
Clinical research (27185)
Collaboration (272)
Compensation (282)
Complete response letters (8)
COVID-19 (667)
CRISPR (8)
C-suite (103)
Cystic fibrosis (29)
Data (754)
Decentralized trials (1)
Denatured (12)
Depression (15)
Diabetes (63)
Diagnostics (606)
Digital health (2)
Diversity (6)
Diversity, equity & inclusion (19)
Drug discovery (31)
Drug pricing (23)
Drug shortages (3)
Duchenne muscular dystrophy (21)
Earnings (23220)
Editorial (27)
Employer branding (10)
Employer resources (60)
Events (34065)
Executive appointments (311)
FDA (3105)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (208)
Gene editing (19)
Generative AI (9)
Gene therapy (69)
GLP-1 (252)
Government (749)
Grass and pollen (1)
Guidances (15)
Healthcare (2333)
Huntington's disease (9)
IgA nephropathy (7)
Immunology and inflammation (35)
Indications (12)
Infectious disease (702)
Inflammatory bowel disease (47)
Inflation Reduction Act (6)
Influenza (8)
Intellectual property (37)
Interviews (59)
IPO (5817)
IRA (14)
Job creations (1032)
Job search strategy (263)
Kidney cancer (5)
Labor market (27)
Layoffs (136)
Leadership (13)
Legal (917)
Liver cancer (23)
Lung cancer (104)
Lymphoma (47)
Machine learning (2)
Management (23)
Manufacturing (115)
MASH (40)
Medical device (451)
Medtech (452)
Mergers & acquisitions (4270)
Metabolic disorders (230)
Multiple sclerosis (31)
NASH (8)
Neurodegenerative disease (28)
Neuropsychiatric disorders (7)
Neuroscience (567)
NextGen: Class of 2025 (987)
Non-profit (244)
Northern California (1072)
Now hiring (29)
Obesity (123)
Opinion (79)
Ovarian cancer (30)
Pain (25)
Pancreatic cancer (21)
Parkinson's disease (41)
Partnered (3)
Patents (71)
Patient recruitment (43)
Peanut (15)
People (17368)
Pharmaceutical (38)
Pharmacy benefit managers (1)
Phase I (8226)
Phase II (12526)
Phase III (9138)
Pipeline (466)
Policy (69)
Postmarket research (513)
Preclinical (3073)
Press Release (19)
Prostate cancer (22)
Psychedelics (12)
Radiopharmaceuticals (111)
Rare diseases (106)
Real estate (1210)
Recruiting (29)
Regulatory (5765)
Reports (22)
Research institute (285)
Resumes & cover letters (40)
RNA editing (1)
RSV (13)
Schizophrenia (39)
Series A (35)
Series B (23)
Service/supplier (4)
Sickle cell disease (8)
Southern California (866)
Special edition (16)
Spinal muscular atrophy (43)
Sponsored (5)
Startups (963)
State (1)
Stomach cancer (1)
Supply chain (17)
Tariffs (17)
The Weekly (34)
United States (8014)
Vaccines (170)
Venture capitalists (16)
Weight loss (58)
Women's health (7)
Worklife (12)
Date
Today (6)
Last 7 days (160)
Last 30 days (827)
Last 365 days (11751)
2025 (3385)
2024 (12613)
2023 (14388)
2022 (16256)
2021 (17925)
2020 (15280)
2019 (10080)
2018 (7202)
2017 (9001)
2016 (7372)
2015 (9341)
2014 (7087)
2013 (5103)
2012 (4935)
2011 (4867)
2010 (4844)
Location
Africa (172)
Alabama (18)
Arizona (25)
Arkansas (2)
Asia (13580)
Australia (1492)
California (2250)
Canada (518)
China (313)
Colorado (80)
Connecticut (90)
Delaware (73)
Europe (24662)
Florida (283)
Georgia (71)
Idaho (3)
Illinois (107)
India (8)
Indiana (82)
Iowa (5)
Japan (62)
Kansas (52)
Kentucky (7)
Maine (2)
Maryland (234)
Massachusetts (1786)
Michigan (35)
Minnesota (78)
Missouri (17)
Nebraska (6)
Nevada (4)
New Hampshire (4)
New Jersey (812)
New Mexico (7)
New York (763)
North Carolina (354)
Northern California (1072)
Ohio (67)
Oklahoma (4)
Oregon (12)
Pennsylvania (416)
Puerto Rico (7)
Rhode Island (8)
South America (214)
Southern California (866)
Tennessee (8)
Texas (220)
Utah (51)
Virginia (42)
Washington D.C. (13)
Washington State (150)
Wisconsin (9)
171,037 Results for "arca biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
ARCA biopharma, Inc. reported first quarter 2024 financial results and provided a corporate update.
April 25, 2024
·
14 min read
Business
ARCA biopharma Announces 2023 Financial Results
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported 2023 financial results and provided a corporate update.
February 1, 2024
·
6 min read
Deals
Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel Treatments for Chronic Skin Diseases
Paragon Therapeutics announced today that the third company founded based on assets generated by Paragon, Oruka Therapeutics (“Oruka”), has entered into a definitive agreement with ARCA biopharma to combine the companies in an all-stock transaction.
April 3, 2024
·
3 min read
Press Releases
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics
August 19, 2024
·
11 min read
Business
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
August 29, 2024
·
5 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
April 3, 2025
·
1 min read
·
Angela Gabriel
Business
ARCA biopharma Announces Third Quarter 2023 Financial Results
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported third quarter 2023 financial results and provided a corporate update.
October 18, 2023
·
5 min read
Business
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
August 26, 2024
·
9 min read
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
·
3 min read
·
BioSpace Editorial Staff
Press Releases
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
September 3, 2024
·
6 min read
1 of 17,104
Next
